TAIDOC TECHNOLOGY CORP
TaiDoc Technology Corporation manufactures and markets medical devices in Taiwan and internationally. The company offers In vitro diagnostics products, including multiple parameter monitoring systems, point of care testing devices, and lancet and lancing devices; vet health care products comprise blood glucose and calcium meters, and blood ketone meters; and medical devices, such as nebulizers, t… Read more
TAIDOC TECHNOLOGY CORP - Asset Resilience Ratio
TAIDOC TECHNOLOGY CORP (4736) has an Asset Resilience Ratio of 23.74% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2009–2024)
This chart shows how TAIDOC TECHNOLOGY CORP's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down TAIDOC TECHNOLOGY CORP's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$3.04 Billion | 23.74% |
| Total Liquid Assets | NT$3.04 Billion | 23.74% |
Asset Resilience Insights
- Good Liquidity Position: TAIDOC TECHNOLOGY CORP maintains a healthy 23.74% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
TAIDOC TECHNOLOGY CORP Industry Peers by Asset Resilience Ratio
Compare TAIDOC TECHNOLOGY CORP's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022 |
Medical Devices | 0.01% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.26% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 7.79% |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932 |
Medical Devices | 6.64% |
|
Shinhung
KO:004080 |
Medical Devices | 4.17% |
|
UMediC Group Berhad
KLSE:0256 |
Medical Devices | 1.48% |
|
Osang Healthcare Co.,Ltd
KQ:036220 |
Medical Devices | 9.34% |
|
HansBiomed Corporation
KQ:042520 |
Medical Devices | 9.13% |
Annual Asset Resilience Ratio for TAIDOC TECHNOLOGY CORP (2009–2024)
The table below shows the annual Asset Resilience Ratio data for TAIDOC TECHNOLOGY CORP.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-09-30 | 20.88% | NT$2.56 Billion | NT$12.24 Billion | +11.31pp |
| 2023-09-30 | 9.57% | NT$1.14 Billion | NT$11.91 Billion | -0.51pp |
| 2022-09-30 | 10.07% | NT$1.30 Billion | NT$12.90 Billion | +7.79pp |
| 2021-09-30 | 2.29% | NT$240.87 Million | NT$10.52 Billion | +1.55pp |
| 2020-09-30 | 0.73% | NT$67.38 Million | NT$9.17 Billion | +0.15pp |
| 2019-09-30 | 0.59% | NT$46.06 Million | NT$7.83 Billion | -0.31pp |
| 2018-09-30 | 0.90% | NT$67.53 Million | NT$7.53 Billion | +0.04pp |
| 2017-09-30 | 0.85% | NT$51.68 Million | NT$6.06 Billion | 0.00pp |
| 2016-09-30 | 0.86% | NT$43.39 Million | NT$5.07 Billion | -0.10pp |
| 2015-09-30 | 0.96% | NT$41.53 Million | NT$4.34 Billion | +0.93pp |
| 2014-09-30 | 0.02% | NT$907.00K | NT$3.96 Billion | +0.02pp |
| 2013-09-30 | 0.01% | NT$179.00K | NT$3.19 Billion | -0.31pp |
| 2010-09-30 | 0.32% | NT$9.73 Million | NT$3.07 Billion | -0.13pp |
| 2009-09-30 | 0.44% | NT$11.83 Million | NT$2.66 Billion | -- |